SynthesisSleep & breathing = Schlaf & Atmung2025
Prevalence of cognitive impairment among adults with obstructive sleep apnea: a systematic review and meta-analysis.
Synthesis in Sleep & breathing = Schlaf & Atmung, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Neuroscience-guided bilateral thalamic MRI deep learning for obstructive sleep apnea diagnosis: a dual-center translational study.BMC psychiatry · 2026Article
- CPAP Treatment Exposure, but Not Daytime Sleepiness or Neurofilament Light Chain, Is Associated with Cognitive Performance in Obstructive Sleep Apnea.Journal of clinical medicine · 2026Article
- Neurocognitive Recovery Following Continuous Positive Airway Pressure Therapy in Patients with Moderate to Severe Obstructive Sleep Apnea.Journal of clinical medicine · 2025Article
- Association of Excessive Daytime Sleepiness With Long-Term Incident Dementia: The Role of β-Amyloid and White Matter Injury.Alzheimer's & dementia (New York, N. Y.)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposeCognitive impairment in obstructive sleep apnea (OSA) poses a growing public health challenge. This systematic review and meta-analysis aims to estimate the prevalence of cognitive impairment among adults with OSA.
methodsWe systematically searched PubMed, Embase, Cochrane Library, and Web of Science from database inception to February 2, 2025 for studies on cognitive impairment in OSA adults. OSA diagnosis requires formal clinical confirmation through objective testing; cognitive impairment is assessed using validated standardized instruments. Meta-analysis was executed via Stata 17.0, with publication bias assessed by funnel plots and Egger's test.
resultsAcross 23 studies involving 33,226 individuals, the pooled prevalence of cognitive impairment among adult OSA patients was 36.92% (95% CI: 26.62-47.23). Subgroup analyses indicated that the prevalence of 32.22% (95% CI: 12.57-55.60) in mild OSA cases, 36.79% (95% CI: 11.13-67.06) in moderate cases, and 44.46% (95% CI: 30.38-58.98) in severe cases; polysomnography (PSG)-based studies reported a higher prevalence at 38.61% (95% CI: 31.94-45.27) than home sleep apnea testing (HSAT) at 26.85% (95% CI: 19.34-34.36). Prevalence varied significantly by cognitive assessment tool: Montreal Cognitive Assessment (MoCA) yielded 42.20% (95% CI: 34.83-49.57), Mini-Mental State Examination (MMSE) 17.51% (95% CI: 14.07-20.94), Clinical Dementia Rating (CDR) 54.24% (95% CI: 40.75-67.28), and Critical Flicker Frequency (CFF) 27.66% (95% CI: 15.62-42.64). The South-East Asia Region exhibited the highest pooled prevalence at 62.32% (95% CI: 56.86-67.78), followed by the Western Pacific Region at 37.70% (95% CI: 28.50-46.91), the Region of the Americas at 34.21% (95% CI: 5.68-62.74), the Eastern Mediterranean Region at 33.25% (95% CI: 29.91-36.71), and the European Region at 24.89% (95% CI: 19.26-30.52); 46.98% (95% CI, 27.86-66.10) in males and 59.24% (95% CI, 53.20-65.29) in females.
conclusionThe high prevalence of cognitive impairment among adults with OSA highlights the need for increased attention from public health departments. Multinational longitudinal studies using standardized protocols are needed to optimize relevant evidence-based management strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.